Contribution of endogenous carbon monoxide to regulation of diameter in resistance vessels

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 276, Issue 4 45-4, 1999, Pages

  Kozma, Fruzsina ^a   Johnson, Robert A ^a   Zhang, Fan ^a   Yu, Changhua ^a   Tong, Xianglan ^a   Nasjletti, Alberto ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Heme; Heme oxygenase; Heme oxygenase inhibitors; Vasodilatory mechanisms

Indexed keywords

CARBON MONOXIDE; CYCLIC GMP; GUANYLATE CYCLASE; HEME; HEME OXYGENASE; HEME OXYGENASE INHIBITOR; MESOPORPHYRIN CHROMIUM; PORPHYRIN COBALT; PORPHYRIN DERIVATIVE; PROTOPORPHYRIN MAGNESIUM; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTERIOLE; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL DIAMETER; CONTROLLED STUDY; GRACILIS MUSCLE; MALE; MUSCLE ISOMETRIC CONTRACTION; MUSCLE TONE; NONHUMAN; PRIORITY JOURNAL; RAT; RESISTANCE BLOOD VESSEL; VASODILATATION;

EID: 0032960103     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1999.276.4.r1087     Document Type: Article

References (35)

1. Chakder, S., S. Rathi, X.-L. Ma, and S. Rattan. Heme oxygenase inhibitor zinc protoporphyrin IX causes an activation of nitric oxide synthase in the rabbit internal anal sphincter. J. Pharmacol. Exp. Ther. 277: 1376-1382, 1996.
2. Christodoulides, N., W. Durante, M. H. Kroll, and A. I. Schafer. Vascular smooth muscle cell heme oxygenases generate guanylyl cyclase-stimulatory carbon monoxide. Circulation 91: 2306-2309, 1995.
3. Coceani, F. Control of the ductus arteriosus - a new function for cytochrome P450, endothelin and nitric oxide. Biochem. Pharmacol. 48: 1315-1318, 1994.
4. Coceani, F., L. Kelsey, and E. Seidlitz. Carbon monoxide-induced relaxation of the ductus arteriosus in the lamb: evidence against the prime role of guanylyl cyclase. Br. J. Pharmacol. 118: 1689-1696, 1996.
5. Coceani, F., L. Kelsey, E. Seidlitz, G. S. Marks, B. E. McLaughlin, H. J. Vreman, D. K. Stevenson, M. Rabinovitch, and C. Ackerley. Carbon monoxide formation in the ductus arteriosus in the lamb: implications for the regulation of muscle tone. Br. J. Pharmacol. 120: 599-608, 1997.
6. Cook, M. N., K. Marks, G. S. Nakatsu, B. E. McLaughlin, H. J. Vreman, D. K. Stevenson, and J. F. Brien. Heme oxygenase activity in the adult rat aorta and liver as measured by carbon monoxide formation. Can. J. Physiol. Pharmacol. 73: 515-518, 1995.
7. Drummond, G. S., D. W. Rosenberg, and A. Kappas. Intestinal heme oxygenase inhibition and increased biliary iron excretion by metalloporphyrins. Gastroenterology 102: 1170-1175, 1992.
8. Estabrook, R. W., M. R. Franklin, and A. G. Hildebrandt. Factors influencing the inhibitory effect of carbon monoxide on cytochrome P-450-catalyzed mixed function oxidation reactions. Ann. NY Acad. Sci. 174: 218-232, 1970.
9. Furchgott, R. F., and D. Jothianandan. Endothelium-dependent and -independent vasodilation involving cyclic GMP: relaxation induced by nitric oxide, carbon monoxide and light. Blood Vessels 28: 52-61, 1991.
10. Grozdanovic, Z., and R. Gossrau. Expression of heme oxygenase-2 (HO-2)-like immunoreactivity in rat tissues. Acta Histochem. 98: 203-214, 1996.
11. Grundemar, L., M.-B. Johansson, M. Ekelund, and E. D. Högestätt. Haem oxygenase activity in blood vessel homogenates as measured by carbon monoxide production. Acta Physiol. Scand. 153: 203-204, 1995.
12. Grundemar, L., and L. Ny. Pitfalls using metalloporphyrins in carbon monoxide research. Trends Pharmacol. Sci. 18: 193-195, 1997.
13. Hussain, A. S., G. S. Marks, J. F. Brien, and K. Nakatsu. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) inhibits relaxation of rabbit aortic rings induced by carbon monoxide, nitric oxide, and glyceryl trinitrate. Can. J. Physiol. Pharmacol. 75: 1034-1037, 1997.
14. Ignarro, L. J. Regulation of cytosolic guanylyl cyclase by porphyrins and metalloporphyrins. Acta. Pharmacol. 26: 35-65, 1994.
15. Johnson, R. A., M. Lavesa, B. Askari, N. G. Abraham, and A. Nasjletti. A heme oxygenase product, presumably carbon monoxide, mediates a vasodepressor function in rats. Hypertension 25: 166-169, 1995.
16. Johnson, R. A., M. Lavesa, K. DeSeyn, M. J. Scholer, and A. Nasjletti. Heme oxygenase substrates acutely lower blood pressure in hypertensive rats. Am. J. Physiol. 271 (Heart Circ. Physiol. 40): H1132-H1138, 1996.
17. Kharitonov, V. G., V. S. Sharma, R. B. Pilz, D. Magde, and D. Koesling. Basis of guanylate cyclase activation by carbon monoxide. Proc. Natl. Acad. Sci. USA 92: 2568-2571, 1995.
18. Kozma, F., R. A. Johnson, and A. Nasjletti. Role of carbon monoxide in heme-induced vasodilation. Eur. J. Pharmacol. 323: R1-R2, 1997.
19. Lin, H., and J. J. McGrath. Vasodilating effects of carbon monoxide. Drug Chem. Toxicol. 11: 371-385, 1988.
20. Maines, M. D. The heme oxygenase system: a regulator cf second messenger gases. Annu. Rev. Pharmacol. Toxicol. 37: 517-554, 1997.
21. Marks, G. S., J. F. Brien, K. Nakatsu, and B. E. McLaughlin. Does carbon monoxide have a physiological function? Trends Pharmacol. Sci. 12: 185-188, 1991.
22. Morita, T., and S. Kourembanas. Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide. J. Clin. Invest. 96: 2676-2682, 1995.
23. Motterlini, R., A. Gonzales, R. Foresti, J. E., Clark, C. J. Green, and R. M. Winslow. Heme-oxygenase-1 derived carbon monoxide contributes to the suppression of acute hypertensive responses in vivo. Circ. Res. 83: 568-577, 1998.
24. Mulvany, M. J., and W. Halpern. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ. Res. 41: 19-26, 1977.
25. Osol, G. Mechanotransduction by vascular smooth muscle. J. Vasc. Res. 32: 275-292, 1995.
26. G-nitro-L-arginine. Br. J. Pharmacol. 118: 1433-1440, 1996.
27. Ramos, K. S., H. Lin, and J. J. McGrath. Modulation of cyclic guanosine monophosphate levels in cultured aortic smooth muscle cells by carbon monoxide. Biochem. Pharmacol. 38: 1368-1370, 1989.
28. Sellers, V. M., M. K. Johnson, and H. A. Dailey. Function of the [2Fe-2S] cluster in mammalian ferrochelatase: a possible role as a nitric oxide sensor. Biochemistry 55: 2699-2704, 1996.
29. Sun, D., G. Kaley, and A. Koller. Characteristics and origin of myogenic response in isolated gracilis muscle arterioles. Am. J. Physiol. 266 (Heart Circ. Physiol. 35): H1177-H1183, 1994.
30. Tenhunen, R., O. Tokola, and I.-B. Lindén. Haem arginate: a new stable haem compound. J. Pharm. Pharmacol. 39: 780-786, 1987.
31. Vreman, H. J., B. C. Ekstrand, and D. K. Stevenson. Selection of metalloporphyrin heme oxygenase inhibitors based on potency and photoreactivity. Pediatr. Res. 33: 195-200, 1993.
32. Wang, R., Z. Wang, and L. Wu. Carbon monoxide-induced vasorelaxation and the underlying mechanisms. Br. J. Pharmacol. 121: 927-934, 1997.
33. Ca channels in vascular smooth muscle cells. Pflügers Arch. 434: 285-291, 1997.
34. Williams, D. L., Jr., K. L. Murphy, N. A. Nolan, J. A. O'Brien, D. J. Pettibone, S. D. Kivlighn, S. M. Krause, E. V. Lis, Jr., G. J. Zingaro, R. A. Gabel, F. C. Clayton, P. K. S. Siegl, K. Zhang, J. Naue, K. Vyas, T. F. Walsh, K. J. Fitch, P. K. Chakravarty, W. J. Greenlee, B. V. Clineschmidt. Pharmacology of L-754,142, a highly potent, orally active, nonpeptidyl endothelin antagonist. J. Pharmacol. Exp. Ther. 275: 1518-1526, 1995.
35. Zakhary, R., S. P. Gaine, J. L. Dinerman, M. Ruat, N. A. Flavahan, and S. H. Snyder. Heme oxygenase 2: endothelial and neuronal localization and role in endothelium-dependent relaxation. Proc. Natl. Acad. Sci. USA 93: 795-798, 1996.